| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nociceptors | 75 | 2024 | 460 | 8.620 |
Why?
|
| Pain | 111 | 2024 | 5090 | 7.690 |
Why?
|
| Ganglia, Spinal | 90 | 2024 | 529 | 6.930 |
Why?
|
| Neurons, Afferent | 72 | 2014 | 498 | 6.190 |
Why?
|
| Spinal Cord | 103 | 2024 | 1811 | 5.350 |
Why?
|
| Sensory Receptor Cells | 32 | 2024 | 509 | 5.000 |
Why?
|
| Hyperalgesia | 51 | 2024 | 531 | 4.880 |
Why?
|
| Nerve Regeneration | 46 | 2023 | 800 | 4.750 |
Why?
|
| Neuralgia | 31 | 2024 | 627 | 4.550 |
Why?
|
| Axons | 47 | 2024 | 1677 | 3.710 |
Why?
|
| Sciatic Nerve | 51 | 2021 | 624 | 3.580 |
Why?
|
| Analgesics | 29 | 2022 | 1067 | 3.570 |
Why?
|
| Posterior Horn Cells | 22 | 2024 | 87 | 3.210 |
Why?
|
| Pain Threshold | 36 | 2019 | 609 | 3.170 |
Why?
|
| Motor Neurons | 34 | 2024 | 871 | 2.520 |
Why?
|
| Peripheral Nervous System Diseases | 17 | 2024 | 713 | 2.310 |
Why?
|
| Sodium Channel Blockers | 8 | 2021 | 171 | 2.180 |
Why?
|
| Afferent Pathways | 33 | 2014 | 303 | 2.180 |
Why?
|
| Activating Transcription Factor 3 | 6 | 2021 | 61 | 2.170 |
Why?
|
| Neuronal Plasticity | 25 | 2020 | 1447 | 2.110 |
Why?
|
| Rats | 198 | 2024 | 23717 | 2.090 |
Why?
|
| Rats, Sprague-Dawley | 106 | 2024 | 8113 | 2.050 |
Why?
|
| Peripheral Nerves | 29 | 2014 | 491 | 2.050 |
Why?
|
| Inflammation | 46 | 2024 | 10860 | 1.800 |
Why?
|
| Analgesia | 12 | 2023 | 461 | 1.790 |
Why?
|
| Pain Measurement | 36 | 2022 | 3576 | 1.780 |
Why?
|
| TRPV Cation Channels | 14 | 2023 | 242 | 1.730 |
Why?
|
| Animals | 350 | 2024 | 168800 | 1.720 |
Why?
|
| Nerve Fibers | 39 | 2012 | 704 | 1.610 |
Why?
|
| Lidocaine | 12 | 2019 | 545 | 1.590 |
Why?
|
| Neurons | 51 | 2024 | 9521 | 1.560 |
Why?
|
| Synaptic Transmission | 25 | 2016 | 1175 | 1.540 |
Why?
|
| Peripheral Nervous System | 8 | 2022 | 151 | 1.390 |
Why?
|
| Nerve Growth Factors | 18 | 2003 | 564 | 1.360 |
Why?
|
| Sodium Channels | 10 | 2019 | 339 | 1.320 |
Why?
|
| Amyotrophic Lateral Sclerosis | 11 | 2021 | 1482 | 1.280 |
Why?
|
| Pruritus | 5 | 2024 | 376 | 1.270 |
Why?
|
| Sciatic Neuropathy | 7 | 2015 | 76 | 1.270 |
Why?
|
| Induced Pluripotent Stem Cells | 12 | 2024 | 1884 | 1.230 |
Why?
|
| Neuroimmunomodulation | 3 | 2024 | 186 | 1.210 |
Why?
|
| Neurites | 13 | 2022 | 389 | 1.190 |
Why?
|
| Capsaicin | 22 | 2017 | 230 | 1.150 |
Why?
|
| Neural Inhibition | 13 | 2014 | 589 | 1.150 |
Why?
|
| Behavior, Animal | 23 | 2020 | 1867 | 1.120 |
Why?
|
| Synapses | 22 | 2018 | 1759 | 1.070 |
Why?
|
| Nerve Fibers, Myelinated | 22 | 2003 | 951 | 1.050 |
Why?
|
| Mice | 107 | 2024 | 81839 | 1.040 |
Why?
|
| Morphine | 16 | 2017 | 661 | 1.040 |
Why?
|
| Physical Stimulation | 27 | 2021 | 514 | 1.000 |
Why?
|
| Central Nervous System | 16 | 2009 | 1343 | 0.970 |
Why?
|
| GTP Cyclohydrolase | 8 | 2022 | 47 | 0.950 |
Why?
|
| Gene Expression Regulation | 22 | 2022 | 11906 | 0.950 |
Why?
|
| Disease Models, Animal | 33 | 2024 | 18321 | 0.920 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 14 | 2008 | 904 | 0.910 |
Why?
|
| Hot Temperature | 14 | 2024 | 1440 | 0.910 |
Why?
|
| Schwann Cells | 6 | 2014 | 195 | 0.870 |
Why?
|
| Nerve Tissue Proteins | 26 | 2017 | 4399 | 0.870 |
Why?
|
| Somatosensory Cortex | 4 | 2024 | 508 | 0.860 |
Why?
|
| Mechanoreceptors | 16 | 2020 | 194 | 0.840 |
Why?
|
| Bradykinin | 5 | 2008 | 205 | 0.840 |
Why?
|
| Touch | 9 | 2018 | 313 | 0.830 |
Why?
|
| Reflex | 17 | 2017 | 375 | 0.790 |
Why?
|
| Spinal Cord Injuries | 7 | 2023 | 929 | 0.780 |
Why?
|
| Substance P | 15 | 2024 | 331 | 0.780 |
Why?
|
| Mice, Inbred C57BL | 40 | 2024 | 22341 | 0.780 |
Why?
|
| Vincristine | 1 | 2024 | 1037 | 0.770 |
Why?
|
| DNA Breaks | 1 | 2021 | 47 | 0.760 |
Why?
|
| Neuropeptides | 8 | 2016 | 950 | 0.750 |
Why?
|
| Spinal Nerves | 9 | 2020 | 93 | 0.740 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2021 | 108 | 0.740 |
Why?
|
| Nervous System | 6 | 2009 | 542 | 0.720 |
Why?
|
| Drug Discovery | 4 | 2021 | 1065 | 0.710 |
Why?
|
| Freund's Adjuvant | 13 | 2022 | 145 | 0.680 |
Why?
|
| Axotomy | 12 | 2020 | 71 | 0.670 |
Why?
|
| Receptors, Opioid, mu | 5 | 2023 | 167 | 0.670 |
Why?
|
| Heat-Shock Proteins | 6 | 2018 | 790 | 0.670 |
Why?
|
| Skin | 31 | 2024 | 4482 | 0.660 |
Why?
|
| Research Personnel | 1 | 2024 | 589 | 0.660 |
Why?
|
| Recovery of Function | 5 | 2020 | 2971 | 0.650 |
Why?
|
| Neuroglia | 4 | 2022 | 963 | 0.640 |
Why?
|
| Spinal Nerve Roots | 10 | 2009 | 122 | 0.640 |
Why?
|
| Hypersensitivity | 8 | 2024 | 1168 | 0.630 |
Why?
|
| Reaction Time | 12 | 2017 | 2086 | 0.630 |
Why?
|
| Models, Neurological | 8 | 2015 | 1746 | 0.630 |
Why?
|
| Neuroprotective Agents | 3 | 2024 | 959 | 0.630 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2016 | 1140 | 0.630 |
Why?
|
| Metaplasia | 1 | 2020 | 325 | 0.630 |
Why?
|
| Action Potentials | 22 | 2018 | 1834 | 0.620 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 4 | 2004 | 319 | 0.610 |
Why?
|
| Patch-Clamp Techniques | 14 | 2014 | 924 | 0.610 |
Why?
|
| Sural Nerve | 17 | 2005 | 105 | 0.600 |
Why?
|
| Anesthetics, Local | 8 | 2018 | 1005 | 0.600 |
Why?
|
| Pain Perception | 2 | 2017 | 197 | 0.600 |
Why?
|
| Diltiazem | 1 | 2018 | 132 | 0.600 |
Why?
|
| Denervation | 14 | 2015 | 265 | 0.600 |
Why?
|
| Vagus Nerve | 2 | 2021 | 458 | 0.590 |
Why?
|
| Electric Stimulation | 34 | 2010 | 1736 | 0.590 |
Why?
|
| Transient Receptor Potential Channels | 6 | 2014 | 130 | 0.580 |
Why?
|
| Animals, Newborn | 20 | 2016 | 2677 | 0.580 |
Why?
|
| Inflammasomes | 1 | 2023 | 545 | 0.580 |
Why?
|
| Mucus | 1 | 2020 | 346 | 0.580 |
Why?
|
| Sensation | 7 | 2007 | 331 | 0.580 |
Why?
|
| Neurogenic Inflammation | 2 | 2019 | 34 | 0.560 |
Why?
|
| Hindlimb | 19 | 2019 | 512 | 0.560 |
Why?
|
| Cough | 1 | 2021 | 599 | 0.560 |
Why?
|
| Cells, Cultured | 34 | 2024 | 18967 | 0.550 |
Why?
|
| Pain, Postoperative | 7 | 2024 | 1768 | 0.550 |
Why?
|
| Nerve Endings | 8 | 2007 | 103 | 0.540 |
Why?
|
| Membrane Glycoproteins | 14 | 2016 | 3692 | 0.530 |
Why?
|
| Receptors, GABA-A | 5 | 2005 | 624 | 0.510 |
Why?
|
| Neural Cell Adhesion Molecules | 3 | 2005 | 122 | 0.510 |
Why?
|
| N-Methylaspartate | 7 | 2005 | 231 | 0.510 |
Why?
|
| RNA, Messenger | 23 | 2018 | 12775 | 0.510 |
Why?
|
| Isoenzymes | 5 | 2004 | 1688 | 0.510 |
Why?
|
| Sciatica | 4 | 2009 | 98 | 0.500 |
Why?
|
| Retinal Ganglion Cells | 6 | 2024 | 808 | 0.500 |
Why?
|
| Male | 165 | 2024 | 363935 | 0.500 |
Why?
|
| GAP-43 Protein | 14 | 2004 | 152 | 0.500 |
Why?
|
| Cyclooxygenase 2 | 6 | 2009 | 595 | 0.500 |
Why?
|
| Mitogen-Activated Protein Kinases | 6 | 2012 | 1241 | 0.490 |
Why?
|
| Analgesics, Opioid | 12 | 2024 | 3836 | 0.490 |
Why?
|
| Nerve Degeneration | 7 | 2024 | 748 | 0.490 |
Why?
|
| Cytokines | 5 | 2024 | 7426 | 0.490 |
Why?
|
| Humans | 177 | 2024 | 766117 | 0.480 |
Why?
|
| Immune System | 2 | 2012 | 799 | 0.470 |
Why?
|
| Up-Regulation | 13 | 2015 | 4133 | 0.470 |
Why?
|
| Antigens, Ly | 1 | 2015 | 297 | 0.460 |
Why?
|
| Mice, Knockout | 30 | 2024 | 14456 | 0.460 |
Why?
|
| Gene Expression Profiling | 9 | 2024 | 9527 | 0.460 |
Why?
|
| In Situ Hybridization | 16 | 2015 | 1885 | 0.460 |
Why?
|
| Neuromuscular Junction | 2 | 2021 | 399 | 0.460 |
Why?
|
| Airway Remodeling | 1 | 2015 | 134 | 0.450 |
Why?
|
| Aging | 10 | 2024 | 8723 | 0.450 |
Why?
|
| Rats, Inbred Strains | 32 | 1992 | 2077 | 0.430 |
Why?
|
| Ion Channels | 10 | 2016 | 1044 | 0.430 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2015 | 271 | 0.430 |
Why?
|
| Elapidae | 1 | 2013 | 4 | 0.430 |
Why?
|
| Elapid Venoms | 1 | 2013 | 39 | 0.420 |
Why?
|
| Cyclohexanecarboxylic Acids | 2 | 2004 | 140 | 0.410 |
Why?
|
| Decerebrate State | 16 | 1999 | 42 | 0.410 |
Why?
|
| Growth Cones | 6 | 2015 | 117 | 0.410 |
Why?
|
| Phenotype | 14 | 2022 | 16716 | 0.400 |
Why?
|
| Symporters | 2 | 2016 | 362 | 0.400 |
Why?
|
| Wakefulness | 3 | 2017 | 1282 | 0.390 |
Why?
|
| Myelin Proteins | 2 | 2003 | 212 | 0.390 |
Why?
|
| Bupivacaine | 3 | 2019 | 414 | 0.390 |
Why?
|
| Trigeminal Ganglion | 3 | 2024 | 189 | 0.390 |
Why?
|
| Opioid-Related Disorders | 3 | 2024 | 2177 | 0.390 |
Why?
|
| Amines | 2 | 2004 | 281 | 0.390 |
Why?
|
| Interleukin-1 | 5 | 2001 | 1242 | 0.390 |
Why?
|
| Cold Temperature | 7 | 2019 | 794 | 0.380 |
Why?
|
| Signal Transduction | 24 | 2024 | 23605 | 0.380 |
Why?
|
| Alcohol Oxidoreductases | 4 | 2019 | 164 | 0.380 |
Why?
|
| Excitatory Postsynaptic Potentials | 9 | 2005 | 369 | 0.370 |
Why?
|
| Immunohistochemistry | 27 | 2015 | 11035 | 0.370 |
Why?
|
| Evoked Potentials | 23 | 2001 | 1050 | 0.370 |
Why?
|
| Nerve Crush | 12 | 2011 | 77 | 0.370 |
Why?
|
| Receptors, Prostaglandin E | 3 | 2006 | 56 | 0.370 |
Why?
|
| Benzodiazepinones | 2 | 2008 | 50 | 0.360 |
Why?
|
| Muscles | 12 | 1993 | 1576 | 0.360 |
Why?
|
| Convulsants | 2 | 2008 | 70 | 0.360 |
Why?
|
| Mice, Transgenic | 19 | 2018 | 9540 | 0.360 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2010 | 29 | 0.350 |
Why?
|
| Myeloid Cells | 1 | 2015 | 839 | 0.350 |
Why?
|
| Nerve Block | 3 | 2014 | 717 | 0.350 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 519 | 0.350 |
Why?
|
| Motor Activity | 5 | 2021 | 2711 | 0.350 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 848 | 0.340 |
Why?
|
| Dependovirus | 3 | 2015 | 721 | 0.340 |
Why?
|
| Interleukins | 1 | 2015 | 789 | 0.340 |
Why?
|
| Calcitonin Gene-Related Peptide | 8 | 2022 | 326 | 0.330 |
Why?
|
| Valine | 2 | 2010 | 410 | 0.330 |
Why?
|
| Fibroblasts | 4 | 2014 | 4162 | 0.330 |
Why?
|
| Receptors, Opioid, delta | 1 | 2009 | 48 | 0.320 |
Why?
|
| Optic Nerve Injuries | 3 | 2022 | 150 | 0.320 |
Why?
|
| Sodium | 5 | 2023 | 1591 | 0.320 |
Why?
|
| Superoxide Dismutase | 6 | 2015 | 593 | 0.320 |
Why?
|
| Calcium Channels, L-Type | 2 | 2022 | 243 | 0.320 |
Why?
|
| Dizocilpine Maleate | 5 | 2004 | 171 | 0.310 |
Why?
|
| Molecular Chaperones | 4 | 2011 | 760 | 0.310 |
Why?
|
| Excitatory Amino Acid Antagonists | 7 | 2004 | 451 | 0.310 |
Why?
|
| Sensory Thresholds | 6 | 1996 | 377 | 0.310 |
Why?
|
| Electrophysiology | 13 | 2011 | 1263 | 0.310 |
Why?
|
| Enzyme Inhibitors | 11 | 2018 | 3722 | 0.310 |
Why?
|
| Tetrodotoxin | 6 | 2008 | 244 | 0.300 |
Why?
|
| Motor Endplate | 3 | 2011 | 20 | 0.300 |
Why?
|
| Glutamic Acid | 7 | 2005 | 1181 | 0.300 |
Why?
|
| Substantia Gelatinosa | 8 | 1999 | 11 | 0.300 |
Why?
|
| Edema | 2 | 2012 | 763 | 0.290 |
Why?
|
| Anaphylatoxins | 1 | 2007 | 19 | 0.290 |
Why?
|
| Cell Survival | 11 | 2015 | 5747 | 0.290 |
Why?
|
| Macrophages | 6 | 2024 | 5776 | 0.290 |
Why?
|
| Cell Death | 7 | 2013 | 1676 | 0.290 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2017 | 1245 | 0.290 |
Why?
|
| Blotting, Northern | 7 | 2008 | 1546 | 0.290 |
Why?
|
| Receptors, Drug | 3 | 2002 | 156 | 0.290 |
Why?
|
| Cell Membrane Permeability | 2 | 2007 | 565 | 0.290 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2011 | 844 | 0.290 |
Why?
|
| Sulfasalazine | 2 | 2019 | 85 | 0.280 |
Why?
|
| Receptors, AMPA | 3 | 2008 | 335 | 0.280 |
Why?
|
| Repressor Proteins | 3 | 2022 | 2974 | 0.280 |
Why?
|
| Anterior Horn Cells | 3 | 2002 | 17 | 0.280 |
Why?
|
| Neurofilament Proteins | 6 | 2010 | 335 | 0.280 |
Why?
|
| Dinoprostone | 4 | 2022 | 593 | 0.280 |
Why?
|
| Complement C5a | 1 | 2007 | 98 | 0.280 |
Why?
|
| Running | 1 | 2012 | 488 | 0.280 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 7600 | 0.280 |
Why?
|
| Drug Evaluation, Preclinical | 4 | 2021 | 1331 | 0.270 |
Why?
|
| Gene Expression | 7 | 2021 | 7582 | 0.270 |
Why?
|
| Nerve Growth Factor | 3 | 2022 | 156 | 0.270 |
Why?
|
| Naloxone | 10 | 1995 | 373 | 0.270 |
Why?
|
| Receptors, Neurokinin-1 | 3 | 2017 | 133 | 0.270 |
Why?
|
| Receptors, Cell Surface | 5 | 2007 | 2815 | 0.260 |
Why?
|
| Time Factors | 30 | 2015 | 40108 | 0.260 |
Why?
|
| Receptors, GABA | 1 | 2008 | 312 | 0.250 |
Why?
|
| Receptors, Neurokinin-2 | 3 | 1995 | 24 | 0.250 |
Why?
|
| Growth Inhibitors | 2 | 1998 | 375 | 0.250 |
Why?
|
| Neurologic Examination | 1 | 2009 | 913 | 0.250 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2005 | 70 | 0.250 |
Why?
|
| Microglia | 4 | 2008 | 1371 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2015 | 3796 | 0.250 |
Why?
|
| Myelin Sheath | 3 | 2003 | 651 | 0.250 |
Why?
|
| Serotonin | 5 | 2024 | 1045 | 0.250 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 1423 | 0.250 |
Why?
|
| Preanesthetic Medication | 2 | 1995 | 48 | 0.250 |
Why?
|
| Cell Size | 4 | 2016 | 626 | 0.240 |
Why?
|
| HSP27 Heat-Shock Proteins | 3 | 2012 | 67 | 0.240 |
Why?
|
| Injections, Spinal | 9 | 2006 | 318 | 0.240 |
Why?
|
| Protein Kinase C | 4 | 2017 | 1205 | 0.240 |
Why?
|
| Caspases | 2 | 2005 | 881 | 0.240 |
Why?
|
| Calcium Signaling | 4 | 2019 | 734 | 0.240 |
Why?
|
| Hyperesthesia | 3 | 2019 | 23 | 0.240 |
Why?
|
| Acetates | 2 | 2004 | 314 | 0.240 |
Why?
|
| Isoxazoles | 2 | 2005 | 233 | 0.230 |
Why?
|
| Long-Term Potentiation | 2 | 2003 | 290 | 0.230 |
Why?
|
| Transcription Factors | 10 | 2024 | 12130 | 0.230 |
Why?
|
| Mutation | 12 | 2023 | 30209 | 0.230 |
Why?
|
| Zymosan | 1 | 2024 | 133 | 0.230 |
Why?
|
| Protein Isoforms | 6 | 2018 | 1716 | 0.230 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2004 | 361 | 0.220 |
Why?
|
| Receptors, Glutamate | 3 | 2004 | 228 | 0.220 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2004 | 111 | 0.220 |
Why?
|
| Rhizotomy | 2 | 2006 | 30 | 0.220 |
Why?
|
| Joints | 3 | 2019 | 321 | 0.220 |
Why?
|
| RGS Proteins | 1 | 2003 | 76 | 0.210 |
Why?
|
| Excitatory Amino Acids | 1 | 2003 | 17 | 0.210 |
Why?
|
| Prostaglandins | 3 | 2002 | 396 | 0.210 |
Why?
|
| Mechanotransduction, Cellular | 2 | 2006 | 539 | 0.210 |
Why?
|
| Interleukin-3 | 1 | 2024 | 423 | 0.210 |
Why?
|
| Time Perception | 1 | 2024 | 87 | 0.210 |
Why?
|
| Calcium | 9 | 2023 | 5770 | 0.210 |
Why?
|
| Membrane Proteins | 9 | 2019 | 7850 | 0.210 |
Why?
|
| Phenylenediamines | 2 | 2021 | 89 | 0.210 |
Why?
|
| Single-Cell Analysis | 3 | 2024 | 2536 | 0.200 |
Why?
|
| Thrombospondin 1 | 1 | 2024 | 256 | 0.200 |
Why?
|
| Enzyme Activation | 8 | 2017 | 3584 | 0.200 |
Why?
|
| Decision Making | 1 | 2016 | 3955 | 0.200 |
Why?
|
| Cell Count | 8 | 2006 | 1825 | 0.200 |
Why?
|
| Female | 69 | 2024 | 396233 | 0.200 |
Why?
|
| Simplexvirus | 2 | 2004 | 805 | 0.200 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2002 | 110 | 0.200 |
Why?
|
| Blotting, Western | 8 | 2015 | 5020 | 0.200 |
Why?
|
| KCNQ3 Potassium Channel | 1 | 2022 | 10 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2024 | 353 | 0.200 |
Why?
|
| Neuroma | 2 | 2023 | 137 | 0.200 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2022 | 19 | 0.200 |
Why?
|
| Protein Kinases | 2 | 2008 | 1611 | 0.200 |
Why?
|
| Growth Substances | 4 | 1996 | 758 | 0.200 |
Why?
|
| Sympathetic Nervous System | 3 | 2007 | 520 | 0.200 |
Why?
|
| Heat-Shock Response | 1 | 2023 | 179 | 0.200 |
Why?
|
| Cell Differentiation | 9 | 2023 | 11642 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2004 | 582 | 0.190 |
Why?
|
| Endorphins | 4 | 1983 | 73 | 0.190 |
Why?
|
| Nerve Fibers, Unmyelinated | 5 | 2008 | 98 | 0.190 |
Why?
|
| Indoles | 4 | 2013 | 1833 | 0.190 |
Why?
|
| Hallux Valgus | 1 | 2002 | 67 | 0.190 |
Why?
|
| Phantom Limb | 1 | 2023 | 106 | 0.190 |
Why?
|
| Phosphorylases | 3 | 1987 | 17 | 0.190 |
Why?
|
| Drug Synergism | 4 | 2018 | 1754 | 0.190 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 5 | 2017 | 2271 | 0.190 |
Why?
|
| Grooming | 1 | 2021 | 39 | 0.190 |
Why?
|
| Enkephalins | 1 | 2002 | 139 | 0.190 |
Why?
|
| Dynorphins | 1 | 2002 | 82 | 0.190 |
Why?
|
| Foot | 6 | 2004 | 576 | 0.190 |
Why?
|
| Carbamates | 2 | 2021 | 191 | 0.190 |
Why?
|
| Apoptosis | 4 | 2005 | 9508 | 0.190 |
Why?
|
| Ice | 1 | 2022 | 102 | 0.190 |
Why?
|
| Neutrophils | 3 | 2024 | 3771 | 0.190 |
Why?
|
| Membrane Potentials | 8 | 2005 | 1085 | 0.190 |
Why?
|
| Low Back Pain | 2 | 2009 | 987 | 0.190 |
Why?
|
| Pluripotent Stem Cells | 2 | 2023 | 808 | 0.190 |
Why?
|
| Genetic Vectors | 5 | 2006 | 3400 | 0.180 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 855 | 0.180 |
Why?
|
| Electrophysiological Phenomena | 3 | 2022 | 308 | 0.180 |
Why?
|
| Oral Surgical Procedures | 1 | 2002 | 172 | 0.180 |
Why?
|
| Neurobiology | 1 | 2001 | 135 | 0.180 |
Why?
|
| Viscera | 4 | 2005 | 138 | 0.180 |
Why?
|
| Chronic Disease | 7 | 2017 | 9354 | 0.170 |
Why?
|
| Serine | 1 | 2004 | 828 | 0.170 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 465 | 0.170 |
Why?
|
| Isoquinolines | 3 | 2008 | 350 | 0.170 |
Why?
|
| Pterins | 1 | 2019 | 11 | 0.170 |
Why?
|
| Receptors, Adrenergic | 2 | 2017 | 155 | 0.170 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 289 | 0.170 |
Why?
|
| Spider Venoms | 1 | 1999 | 44 | 0.170 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 4249 | 0.170 |
Why?
|
| Cannabidiol | 1 | 2022 | 123 | 0.170 |
Why?
|
| Calcium Channels, N-Type | 1 | 2019 | 42 | 0.170 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 355 | 0.170 |
Why?
|
| Protein Precursors | 2 | 2002 | 1133 | 0.170 |
Why?
|
| Guinea Pigs | 1 | 2021 | 1300 | 0.160 |
Why?
|
| Mustard Plant | 6 | 1998 | 13 | 0.160 |
Why?
|
| Thermosensing | 3 | 2010 | 56 | 0.160 |
Why?
|
| T-Lymphocytes | 5 | 2018 | 10260 | 0.160 |
Why?
|
| Receptors, IgE | 1 | 2021 | 374 | 0.160 |
Why?
|
| Carrier Proteins | 4 | 2011 | 4910 | 0.160 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 945 | 0.160 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 3436 | 0.160 |
Why?
|
| Horseradish Peroxidase | 6 | 1997 | 169 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2006 | 3606 | 0.160 |
Why?
|
| Drug Design | 3 | 2017 | 1040 | 0.160 |
Why?
|
| Calcium Channel Blockers | 2 | 2019 | 686 | 0.150 |
Why?
|
| Tuberous Sclerosis | 2 | 2018 | 1039 | 0.150 |
Why?
|
| NAD | 1 | 2022 | 618 | 0.150 |
Why?
|
| Receptors, Amino Acid | 3 | 1994 | 30 | 0.150 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2018 | 142 | 0.150 |
Why?
|
| Cerebral Cortex | 3 | 2024 | 5758 | 0.150 |
Why?
|
| Plant Oils | 6 | 1998 | 199 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 1138 | 0.150 |
Why?
|
| Ovalbumin | 2 | 2021 | 674 | 0.150 |
Why?
|
| Glutamates | 3 | 1988 | 384 | 0.150 |
Why?
|
| Serine C-Palmitoyltransferase | 2 | 2009 | 41 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13483 | 0.150 |
Why?
|
| Hair | 6 | 2021 | 509 | 0.140 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 2 | 2009 | 41 | 0.140 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 3 | 2005 | 319 | 0.140 |
Why?
|
| Mice, Inbred C3H | 3 | 2015 | 915 | 0.140 |
Why?
|
| Pharmaceutical Preparations | 2 | 2020 | 1084 | 0.140 |
Why?
|
| Temperature | 4 | 2011 | 2227 | 0.140 |
Why?
|
| Interneurons | 5 | 2024 | 593 | 0.140 |
Why?
|
| GPI-Linked Proteins | 5 | 2011 | 472 | 0.140 |
Why?
|
| Drug Tolerance | 1 | 2019 | 365 | 0.140 |
Why?
|
| Cell Communication | 2 | 2016 | 1660 | 0.140 |
Why?
|
| Sensory Gating | 1 | 2017 | 47 | 0.140 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 437 | 0.140 |
Why?
|
| Arthritis, Experimental | 1 | 2019 | 291 | 0.140 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 57 | 0.140 |
Why?
|
| Homeodomain Proteins | 2 | 2004 | 2430 | 0.140 |
Why?
|
| Receptor, trkA | 4 | 2006 | 159 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 1077 | 0.140 |
Why?
|
| Mast Cells | 1 | 2024 | 1404 | 0.140 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 3 | 2007 | 66 | 0.140 |
Why?
|
| Muscle Denervation | 2 | 1993 | 60 | 0.140 |
Why?
|
| Stimulation, Chemical | 6 | 2004 | 303 | 0.140 |
Why?
|
| Antirheumatic Agents | 2 | 2019 | 1380 | 0.140 |
Why?
|
| Brain Mapping | 5 | 2021 | 6595 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2018 | 1393 | 0.140 |
Why?
|
| Cholera Toxin | 5 | 1998 | 562 | 0.130 |
Why?
|
| Aspartic Acid | 3 | 1988 | 575 | 0.130 |
Why?
|
| Palliative Care | 3 | 2000 | 3639 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 10 | 2021 | 10737 | 0.130 |
Why?
|
| Neural Conduction | 6 | 2012 | 442 | 0.130 |
Why?
|
| Pyramidal Tracts | 1 | 2018 | 250 | 0.130 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2004 | 607 | 0.130 |
Why?
|
| Injections | 5 | 2014 | 839 | 0.130 |
Why?
|
| Sulfonamides | 2 | 2005 | 1980 | 0.130 |
Why?
|
| Electric Conductivity | 5 | 2007 | 405 | 0.130 |
Why?
|
| Ligation | 4 | 2005 | 446 | 0.130 |
Why?
|
| Dogs | 1 | 2021 | 3824 | 0.130 |
Why?
|
| Corticosterone | 1 | 2017 | 301 | 0.130 |
Why?
|
| Purkinje Cells | 1 | 2018 | 228 | 0.130 |
Why?
|
| Esophagus | 6 | 2006 | 1039 | 0.130 |
Why?
|
| Video Recording | 1 | 2021 | 977 | 0.130 |
Why?
|
| Chemoreceptor Cells | 2 | 1994 | 87 | 0.130 |
Why?
|
| Glycoproteins | 2 | 2003 | 2196 | 0.130 |
Why?
|
| Receptors, Opioid | 5 | 2023 | 145 | 0.130 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 573 | 0.130 |
Why?
|
| Nucleosomes | 1 | 2019 | 492 | 0.130 |
Why?
|
| Amides | 1 | 2018 | 451 | 0.130 |
Why?
|
| 2-Amino-5-phosphonovalerate | 5 | 2000 | 57 | 0.130 |
Why?
|
| Memory | 2 | 2003 | 2192 | 0.130 |
Why?
|
| Ibuprofen | 1 | 2017 | 228 | 0.130 |
Why?
|
| Cell Separation | 3 | 2017 | 1718 | 0.120 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 1480 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 407 | 0.120 |
Why?
|
| Irritants | 1 | 1995 | 42 | 0.120 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 1651 | 0.120 |
Why?
|
| Lymphokines | 1 | 1998 | 905 | 0.120 |
Why?
|
| Plant Extracts | 6 | 1998 | 496 | 0.120 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 2 | 2012 | 64 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 632 | 0.120 |
Why?
|
| Benzoates | 1 | 2016 | 213 | 0.120 |
Why?
|
| Muscle, Skeletal | 5 | 2014 | 4959 | 0.120 |
Why?
|
| Wounds and Injuries | 5 | 2007 | 2513 | 0.120 |
Why?
|
| Social Behavior | 1 | 2021 | 1143 | 0.120 |
Why?
|
| Gelsolin | 1 | 2015 | 189 | 0.120 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2015 | 179 | 0.120 |
Why?
|
| Tubulin | 1 | 2018 | 694 | 0.120 |
Why?
|
| Immunity, Innate | 2 | 2020 | 3079 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2014 | 414 | 0.120 |
Why?
|
| Interleukin-5 | 1 | 2015 | 268 | 0.120 |
Why?
|
| beta-Endorphin | 1 | 2014 | 43 | 0.120 |
Why?
|
| Receptors, Glycine | 1 | 1994 | 32 | 0.120 |
Why?
|
| Protein Subunits | 3 | 2009 | 940 | 0.120 |
Why?
|
| Leukocyte Elastase | 1 | 2015 | 113 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1765 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 2 | 2016 | 1248 | 0.110 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 368 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2019 | 723 | 0.110 |
Why?
|
| Receptors, Nerve Growth Factor | 3 | 2002 | 199 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2005 | 615 | 0.110 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 624 | 0.110 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1310 | 0.110 |
Why?
|
| Peptides | 3 | 2012 | 4338 | 0.110 |
Why?
|
| Drosophila | 2 | 2012 | 1506 | 0.110 |
Why?
|
| Lactones | 2 | 2009 | 316 | 0.110 |
Why?
|
| Receptors, Growth Factor | 2 | 2005 | 324 | 0.110 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 423 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2004 | 2743 | 0.110 |
Why?
|
| Acute-Phase Proteins | 1 | 2015 | 252 | 0.110 |
Why?
|
| Dysautonomia, Familial | 1 | 2014 | 94 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2022 | 1083 | 0.110 |
Why?
|
| Sulfones | 2 | 2009 | 447 | 0.110 |
Why?
|
| Microtubules | 2 | 2018 | 1064 | 0.110 |
Why?
|
| Histamine Agonists | 1 | 2013 | 13 | 0.110 |
Why?
|
| Molecular Sequence Data | 10 | 2006 | 17597 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1999 | 1962 | 0.110 |
Why?
|
| Dendritic Spines | 1 | 2015 | 244 | 0.110 |
Why?
|
| RNA, Transfer, Tyr | 1 | 2013 | 4 | 0.110 |
Why?
|
| Fever | 7 | 1980 | 1607 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2020 | 1118 | 0.110 |
Why?
|
| Serpins | 1 | 2015 | 244 | 0.110 |
Why?
|
| Antipruritics | 1 | 2013 | 31 | 0.110 |
Why?
|
| Electromyography | 2 | 2017 | 1398 | 0.110 |
Why?
|
| Thalamus | 1 | 2020 | 1040 | 0.110 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 218 | 0.110 |
Why?
|
| Hemolysin Proteins | 1 | 2013 | 112 | 0.110 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 835 | 0.110 |
Why?
|
| Light Signal Transduction | 1 | 2013 | 31 | 0.100 |
Why?
|
| Bacterial Toxins | 2 | 2018 | 924 | 0.100 |
Why?
|
| Thermogenesis | 1 | 2017 | 496 | 0.100 |
Why?
|
| Phosphorylation | 7 | 2014 | 8292 | 0.100 |
Why?
|
| Models, Biological | 4 | 2018 | 9445 | 0.100 |
Why?
|
| Bacterial Load | 1 | 2013 | 156 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2014 | 221 | 0.100 |
Why?
|
| Hydrochloric Acid | 5 | 2006 | 76 | 0.100 |
Why?
|
| Photochemical Processes | 1 | 2013 | 84 | 0.100 |
Why?
|
| Isoindoles | 3 | 1998 | 36 | 0.100 |
Why?
|
| Neural Pathways | 3 | 2018 | 3079 | 0.100 |
Why?
|
| Cell Line | 6 | 2019 | 15546 | 0.100 |
Why?
|
| Premedication | 1 | 1993 | 245 | 0.100 |
Why?
|
| Caffeine | 1 | 2017 | 702 | 0.100 |
Why?
|
| Conditioning, Classical | 1 | 1995 | 368 | 0.100 |
Why?
|
| Axonal Transport | 4 | 1999 | 178 | 0.100 |
Why?
|
| Spinal Injuries | 1 | 1995 | 300 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15882 | 0.100 |
Why?
|
| Amino Acid Sequence | 8 | 2019 | 13400 | 0.100 |
Why?
|
| Foot Injuries | 1 | 2014 | 154 | 0.100 |
Why?
|
| Zinc | 1 | 1996 | 675 | 0.100 |
Why?
|
| Endometriosis | 1 | 2020 | 869 | 0.100 |
Why?
|
| Electrical Synapses | 1 | 2011 | 18 | 0.100 |
Why?
|
| Analysis of Variance | 5 | 2012 | 6208 | 0.100 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 2012 | 86 | 0.100 |
Why?
|
| Ion Transport | 1 | 2013 | 322 | 0.100 |
Why?
|
| Drosophila Proteins | 2 | 2011 | 1704 | 0.100 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 317 | 0.100 |
Why?
|
| Staining and Labeling | 4 | 2000 | 1072 | 0.090 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 947 | 0.090 |
Why?
|
| Neurotoxins | 1 | 1992 | 240 | 0.090 |
Why?
|
| Hysterectomy | 2 | 1995 | 864 | 0.090 |
Why?
|
| Phosphoproteins | 3 | 2016 | 2445 | 0.090 |
Why?
|
| Muscle Contraction | 4 | 1995 | 1207 | 0.090 |
Why?
|
| Protein Stability | 1 | 2013 | 576 | 0.090 |
Why?
|
| Trigeminal Nuclei | 2 | 1981 | 39 | 0.090 |
Why?
|
| Histamine | 1 | 2013 | 495 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1167 | 0.090 |
Why?
|
| Chemokines | 1 | 2015 | 959 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1998 | 1805 | 0.090 |
Why?
|
| Clinical Trials as Topic | 4 | 2015 | 8038 | 0.090 |
Why?
|
| Aplysia | 1 | 1991 | 40 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 347 | 0.090 |
Why?
|
| Efferent Pathways | 2 | 1983 | 164 | 0.090 |
Why?
|
| Benzimidazoles | 1 | 2016 | 862 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 705 | 0.090 |
Why?
|
| TRPC Cation Channels | 1 | 2011 | 108 | 0.090 |
Why?
|
| Epoxide Hydrolases | 1 | 2011 | 122 | 0.090 |
Why?
|
| Lumbar Vertebrae | 1 | 2020 | 1878 | 0.090 |
Why?
|
| Biophysics | 2 | 2009 | 375 | 0.090 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1837 | 0.090 |
Why?
|
| Thermoreceptors | 4 | 1984 | 27 | 0.090 |
Why?
|
| Substance-Related Disorders | 2 | 2017 | 4418 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 2002 | 3594 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1524 | 0.090 |
Why?
|
| Cricetinae | 5 | 2022 | 2413 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2001 | 1657 | 0.090 |
Why?
|
| Benzhydryl Compounds | 1 | 2017 | 943 | 0.090 |
Why?
|
| RNA-Binding Proteins | 2 | 2016 | 1883 | 0.090 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 9601 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2062 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 5791 | 0.080 |
Why?
|
| Arthralgia | 1 | 2013 | 459 | 0.080 |
Why?
|
| Drug Prescriptions | 2 | 2013 | 1662 | 0.080 |
Why?
|
| Tibial Nerve | 4 | 2005 | 55 | 0.080 |
Why?
|
| Ion Channel Gating | 4 | 2007 | 428 | 0.080 |
Why?
|
| Acute Disease | 4 | 2017 | 7237 | 0.080 |
Why?
|
| Autonomic Fibers, Preganglionic | 1 | 2009 | 8 | 0.080 |
Why?
|
| Pyridines | 3 | 2018 | 2889 | 0.080 |
Why?
|
| Patents as Topic | 1 | 2010 | 112 | 0.080 |
Why?
|
| Electronarcosis | 2 | 1979 | 3 | 0.080 |
Why?
|
| Cyclic AMP | 4 | 1987 | 1467 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 3 | 2006 | 1996 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2021 | 20137 | 0.080 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 582 | 0.080 |
Why?
|
| Cobalt | 3 | 1994 | 146 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 424 | 0.080 |
Why?
|
| Paclitaxel | 1 | 2016 | 1727 | 0.080 |
Why?
|
| Transfection | 5 | 2015 | 5739 | 0.080 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2009 | 41 | 0.080 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 1982 | 539 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8924 | 0.080 |
Why?
|
| Phospholipids | 1 | 2012 | 776 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2017 | 484 | 0.080 |
Why?
|
| Haplotypes | 4 | 2008 | 2726 | 0.080 |
Why?
|
| Plants, Medicinal | 3 | 1995 | 165 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4649 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2016 | 1656 | 0.080 |
Why?
|
| Rabbits | 10 | 2000 | 4730 | 0.080 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2210 | 0.080 |
Why?
|
| Glaucoma | 1 | 2018 | 1194 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2013 | 1419 | 0.080 |
Why?
|
| CHO Cells | 4 | 2022 | 1373 | 0.080 |
Why?
|
| Marketing | 1 | 2010 | 225 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4782 | 0.080 |
Why?
|
| Oxadiazoles | 1 | 1988 | 94 | 0.080 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2005 | 46 | 0.080 |
Why?
|
| Research Design | 4 | 2016 | 6206 | 0.070 |
Why?
|
| Embryo, Mammalian | 4 | 2013 | 1674 | 0.070 |
Why?
|
| Interleukin-6 | 1 | 1998 | 3227 | 0.070 |
Why?
|
| Actins | 1 | 2015 | 2061 | 0.070 |
Why?
|
| Smad1 Protein | 2 | 2005 | 81 | 0.070 |
Why?
|
| Drosophila melanogaster | 2 | 2021 | 1725 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2024 | 4746 | 0.070 |
Why?
|
| Sphingolipids | 1 | 2009 | 177 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2002 | 634 | 0.070 |
Why?
|
| Calcium Channels | 2 | 2010 | 622 | 0.070 |
Why?
|
| Autoimmunity | 1 | 2016 | 1354 | 0.070 |
Why?
|
| Receptors, Tachykinin | 2 | 1998 | 25 | 0.070 |
Why?
|
| Skin Physiological Phenomena | 2 | 1986 | 193 | 0.070 |
Why?
|
| Smad Proteins | 2 | 2005 | 157 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2014 | 2718 | 0.070 |
Why?
|
| Nerve Compression Syndromes | 1 | 2009 | 159 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 3690 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2017 | 10380 | 0.070 |
Why?
|
| Microscopy, Electron | 6 | 2003 | 2543 | 0.070 |
Why?
|
| Brain Stem | 2 | 1984 | 852 | 0.070 |
Why?
|
| Small Molecule Libraries | 1 | 2013 | 740 | 0.070 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 85 | 0.070 |
Why?
|
| Vibrissae | 1 | 2008 | 121 | 0.070 |
Why?
|
| Pyrogens | 6 | 1980 | 17 | 0.070 |
Why?
|
| Autonomic Nervous System | 1 | 2012 | 705 | 0.070 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 897 | 0.070 |
Why?
|
| Decision Trees | 1 | 2009 | 509 | 0.070 |
Why?
|
| Ligands | 2 | 2022 | 3274 | 0.070 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 636 | 0.070 |
Why?
|
| Tissue Engineering | 2 | 2021 | 1857 | 0.070 |
Why?
|
| Receptors, Complement | 1 | 2007 | 240 | 0.070 |
Why?
|
| Double-Blind Method | 6 | 2021 | 12426 | 0.070 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2006 | 44 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 2 | 2013 | 910 | 0.070 |
Why?
|
| Embryonic Development | 2 | 2011 | 719 | 0.070 |
Why?
|
| Zebrafish Proteins | 1 | 2013 | 1017 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 7050 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2008 | 694 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 2249 | 0.070 |
Why?
|
| Microelectrodes | 2 | 2001 | 305 | 0.070 |
Why?
|
| Voltage-Dependent Anion Channels | 1 | 2006 | 15 | 0.070 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2007 | 138 | 0.070 |
Why?
|
| Turpentine | 2 | 1996 | 10 | 0.060 |
Why?
|
| Cloning, Molecular | 4 | 2005 | 4163 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 3751 | 0.060 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2005 | 19 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2012 | 731 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1242 | 0.060 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2005 | 25 | 0.060 |
Why?
|
| Acids | 2 | 2004 | 125 | 0.060 |
Why?
|
| Disease Susceptibility | 2 | 2024 | 1790 | 0.060 |
Why?
|
| Radiculopathy | 1 | 2008 | 204 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1997 | 4342 | 0.060 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 1119 | 0.060 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2005 | 68 | 0.060 |
Why?
|
| Astrocytes | 2 | 2005 | 1353 | 0.060 |
Why?
|
| Dendrites | 4 | 2011 | 469 | 0.060 |
Why?
|
| Chest Pain | 2 | 2004 | 1102 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2007 | 308 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3315 | 0.060 |
Why?
|
| Reflex, Abnormal | 1 | 1985 | 83 | 0.060 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2 | 1997 | 36 | 0.060 |
Why?
|
| Facial Nerve | 1 | 2008 | 277 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2010 | 1996 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 287 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2009 | 407 | 0.060 |
Why?
|
| Cesium | 2 | 2013 | 36 | 0.060 |
Why?
|
| Transgenes | 2 | 2023 | 1014 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2007 | 299 | 0.060 |
Why?
|
| Anesthesia, Local | 1 | 2007 | 277 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2008 | 707 | 0.060 |
Why?
|
| Neural Crest | 1 | 2007 | 277 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 295 | 0.060 |
Why?
|
| Allergens | 2 | 2024 | 1435 | 0.060 |
Why?
|
| Species Specificity | 2 | 2024 | 2406 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 3424 | 0.060 |
Why?
|
| Cannabinoids | 1 | 2007 | 174 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4263 | 0.060 |
Why?
|
| Comprehension | 1 | 2010 | 636 | 0.060 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1468 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 2 | 1997 | 316 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3338 | 0.060 |
Why?
|
| Base Sequence | 3 | 2004 | 12405 | 0.060 |
Why?
|
| Quinoxalines | 2 | 2000 | 296 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 2 | 2008 | 261 | 0.060 |
Why?
|
| Parkinson Disease | 1 | 2018 | 2885 | 0.060 |
Why?
|
| Indoleacetic Acids | 1 | 2004 | 44 | 0.060 |
Why?
|
| Histocytochemistry | 3 | 1996 | 695 | 0.060 |
Why?
|
| Prostaglandins E | 5 | 1977 | 166 | 0.060 |
Why?
|
| Reflex, Stretch | 1 | 1984 | 22 | 0.060 |
Why?
|
| Nuclease Protection Assays | 1 | 2004 | 14 | 0.060 |
Why?
|
| Body Temperature Regulation | 2 | 1977 | 292 | 0.060 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2024 | 93 | 0.060 |
Why?
|
| Raphe Nuclei | 2 | 1981 | 104 | 0.060 |
Why?
|
| Syndrome | 1 | 2010 | 3270 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2014 | 5881 | 0.060 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 127 | 0.060 |
Why?
|
| Cricetulus | 2 | 2022 | 807 | 0.060 |
Why?
|
| Omeprazole | 1 | 2004 | 106 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1750 | 0.060 |
Why?
|
| Tritium | 1 | 2004 | 702 | 0.060 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2004 | 83 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2019 | 2927 | 0.060 |
Why?
|
| Melanoma | 1 | 2022 | 5695 | 0.060 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2006 | 349 | 0.060 |
Why?
|
| Dialysis Solutions | 1 | 2004 | 33 | 0.060 |
Why?
|
| Monocytes | 1 | 2013 | 2591 | 0.060 |
Why?
|
| Analgesia, Patient-Controlled | 2 | 1995 | 117 | 0.060 |
Why?
|
| Age Factors | 6 | 2012 | 18386 | 0.050 |
Why?
|
| STAT5 Transcription Factor | 1 | 2024 | 268 | 0.050 |
Why?
|
| Norepinephrine | 3 | 1975 | 898 | 0.050 |
Why?
|
| Microdialysis | 1 | 2004 | 156 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2003 | 119 | 0.050 |
Why?
|
| Autoradiography | 1 | 2004 | 723 | 0.050 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2006 | 352 | 0.050 |
Why?
|
| Brain | 5 | 2022 | 27177 | 0.050 |
Why?
|
| Drug Approval | 1 | 2010 | 820 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2003 | 106 | 0.050 |
Why?
|
| Hair Cells, Auditory | 1 | 2006 | 383 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2004 | 265 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2018 | 2057 | 0.050 |
Why?
|
| Biomedical Research | 3 | 2015 | 3458 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2007 | 617 | 0.050 |
Why?
|
| Opioid Peptides | 1 | 2022 | 37 | 0.050 |
Why?
|
| Body Patterning | 2 | 2005 | 633 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2022 | 67 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2015 | 6059 | 0.050 |
Why?
|
| Atlases as Topic | 1 | 2024 | 247 | 0.050 |
Why?
|
| Tibial Neuropathy | 1 | 2002 | 4 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2879 | 0.050 |
Why?
|
| Lung | 2 | 2020 | 10063 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 855 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 655 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2002 | 48 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 1028 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 123 | 0.050 |
Why?
|
| Biological Products | 1 | 2012 | 947 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2009 | 14645 | 0.050 |
Why?
|
| Biphenyl Compounds | 2 | 2006 | 1019 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 1 | 2002 | 54 | 0.050 |
Why?
|
| Adult | 22 | 2019 | 223139 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2003 | 230 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2002 | 3733 | 0.050 |
Why?
|
| Blood Pressure | 3 | 2015 | 8532 | 0.050 |
Why?
|
| Cyclooxygenase 1 | 1 | 2002 | 98 | 0.050 |
Why?
|
| Molar, Third | 1 | 2002 | 49 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2009 | 6309 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2004 | 565 | 0.050 |
Why?
|
| S100 Proteins | 2 | 1993 | 214 | 0.050 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2002 | 39 | 0.050 |
Why?
|
| Formaldehyde | 2 | 2003 | 360 | 0.050 |
Why?
|
| Macaca | 1 | 2023 | 413 | 0.050 |
Why?
|
| Amino Acids | 1 | 1988 | 1710 | 0.050 |
Why?
|
| Xenopus Proteins | 1 | 2005 | 433 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2022 | 36548 | 0.050 |
Why?
|
| Butadienes | 1 | 2002 | 107 | 0.050 |
Why?
|
| Critical Illness | 1 | 2015 | 2749 | 0.050 |
Why?
|
| Integrases | 2 | 2020 | 520 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2004 | 539 | 0.050 |
Why?
|
| Gangliosides | 1 | 2002 | 132 | 0.050 |
Why?
|
| Phospholipases A | 1 | 2002 | 204 | 0.050 |
Why?
|
| Heterozygote | 3 | 2019 | 2796 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2004 | 1966 | 0.050 |
Why?
|
| Drug Industry | 1 | 2008 | 791 | 0.050 |
Why?
|
| Learning | 2 | 2006 | 1755 | 0.050 |
Why?
|
| Mesencephalon | 2 | 2000 | 337 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 1998 | 1670 | 0.050 |
Why?
|
| Pharmacology, Clinical | 1 | 2001 | 23 | 0.050 |
Why?
|
| Epidermis | 1 | 2024 | 536 | 0.050 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2021 | 26 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2002 | 239 | 0.050 |
Why?
|
| Paresthesia | 1 | 2022 | 159 | 0.050 |
Why?
|
| RNA Interference | 2 | 2010 | 2828 | 0.050 |
Why?
|
| Electroencephalography | 1 | 2017 | 6279 | 0.050 |
Why?
|
| Cation Exchange Resins | 1 | 2001 | 19 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 293 | 0.050 |
Why?
|
| Pharmacists | 1 | 2004 | 261 | 0.050 |
Why?
|
| Proteomics | 1 | 2015 | 3907 | 0.050 |
Why?
|
| Exons | 3 | 2016 | 2393 | 0.050 |
Why?
|
| Leg | 3 | 1996 | 1088 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 562 | 0.050 |
Why?
|
| Light | 2 | 2020 | 1358 | 0.050 |
Why?
|
| Methotrexate | 1 | 2008 | 1719 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 1996 | 415 | 0.050 |
Why?
|
| Tooth Extraction | 1 | 2002 | 225 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 1140 | 0.050 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2021 | 75 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2005 | 743 | 0.050 |
Why?
|
| Trans-Activators | 3 | 2005 | 2849 | 0.050 |
Why?
|
| Professional Role | 1 | 2004 | 314 | 0.050 |
Why?
|
| Arginine Vasopressin | 1 | 1981 | 125 | 0.040 |
Why?
|
| Parents | 1 | 2015 | 3591 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2002 | 280 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2002 | 429 | 0.040 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2002 | 133 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2005 | 965 | 0.040 |
Why?
|
| Eye Movements | 1 | 2024 | 510 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 2016 | 2091 | 0.040 |
Why?
|
| Pain, Intractable | 1 | 2001 | 132 | 0.040 |
Why?
|
| Multigene Family | 1 | 2004 | 1081 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2004 | 1159 | 0.040 |
Why?
|
| Peroneal Nerve | 3 | 2005 | 80 | 0.040 |
Why?
|
| Expressed Sequence Tags | 1 | 2001 | 251 | 0.040 |
Why?
|
| Meglumine | 1 | 2001 | 143 | 0.040 |
Why?
|
| Connexins | 2 | 2013 | 355 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2001 | 456 | 0.040 |
Why?
|
| Dental Pulp | 1 | 1981 | 80 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2021 | 132 | 0.040 |
Why?
|
| Evans Blue | 2 | 1998 | 42 | 0.040 |
Why?
|
| DNA Primers | 2 | 2007 | 2824 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 1999 | 1621 | 0.040 |
Why?
|
| Receptors, Presynaptic | 1 | 2000 | 15 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1068 | 0.040 |
Why?
|
| Protein Binding | 2 | 2019 | 9301 | 0.040 |
Why?
|
| Bucladesine | 5 | 1987 | 117 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 1602 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2004 | 966 | 0.040 |
Why?
|
| Semaphorin-3A | 1 | 1999 | 39 | 0.040 |
Why?
|
| Receptor, Ciliary Neurotrophic Factor | 1 | 1999 | 36 | 0.040 |
Why?
|
| Hypothalamus | 6 | 1980 | 1002 | 0.040 |
Why?
|
| Anxiety | 1 | 2015 | 4672 | 0.040 |
Why?
|
| Proteins | 2 | 2005 | 5995 | 0.040 |
Why?
|
| Cerebellum | 2 | 2018 | 1519 | 0.040 |
Why?
|
| Pons | 1 | 2000 | 239 | 0.040 |
Why?
|
| Physicians | 2 | 2010 | 4591 | 0.040 |
Why?
|
| Sensation Disorders | 1 | 2000 | 160 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 13028 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2022 | 555 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2003 | 1102 | 0.040 |
Why?
|
| Amidines | 1 | 1999 | 28 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2004 | 551 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 238 | 0.040 |
Why?
|
| Culture Techniques | 1 | 1999 | 515 | 0.040 |
Why?
|
| Thapsigargin | 1 | 2018 | 102 | 0.040 |
Why?
|
| Toes | 2 | 1993 | 209 | 0.040 |
Why?
|
| United States | 2 | 2024 | 72920 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2022 | 993 | 0.040 |
Why?
|
| Narcotics | 1 | 2001 | 333 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 2004 | 591 | 0.040 |
Why?
|
| Densitometry | 1 | 1999 | 150 | 0.040 |
Why?
|
| Trigeminal Neuralgia | 1 | 2000 | 108 | 0.040 |
Why?
|
| Isomerism | 1 | 1998 | 197 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2005 | 2244 | 0.040 |
Why?
|
| Stathmin | 1 | 2019 | 70 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2018 | 54 | 0.040 |
Why?
|
| Integrins | 1 | 2023 | 838 | 0.040 |
Why?
|
| Stilbamidines | 1 | 1998 | 43 | 0.040 |
Why?
|
| Neurokinin A | 2 | 1995 | 32 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1998 | 316 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2004 | 1160 | 0.040 |
Why?
|
| Coenzymes | 1 | 2018 | 101 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 1980 | 386 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 920 | 0.040 |
Why?
|
| Oligodendroglia | 1 | 2002 | 543 | 0.040 |
Why?
|
| Thoracic Nerves | 1 | 1978 | 20 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 1998 | 101 | 0.040 |
Why?
|
| Computational Biology | 1 | 2010 | 3565 | 0.040 |
Why?
|
| Cholecystokinin | 1 | 2018 | 114 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 1967 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2001 | 325 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1998 | 81 | 0.040 |
Why?
|
| Salicylates | 2 | 1976 | 125 | 0.040 |
Why?
|
| Gene Library | 1 | 2001 | 1066 | 0.040 |
Why?
|
| Intercostal Nerves | 1 | 1978 | 29 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2018 | 187 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 1999 | 330 | 0.040 |
Why?
|
| Kynurenine | 1 | 2018 | 142 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2019 | 3073 | 0.040 |
Why?
|
| Infusions, Parenteral | 2 | 1993 | 395 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2000 | 1061 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7424 | 0.040 |
Why?
|
| Zebrafish | 2 | 2013 | 3035 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2019 | 487 | 0.040 |
Why?
|
| Cell Movement | 1 | 2009 | 5196 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2001 | 840 | 0.040 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2017 | 13 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2013 | 3051 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2002 | 1179 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 2076 | 0.040 |
Why?
|
| Lumbosacral Region | 2 | 2003 | 295 | 0.040 |
Why?
|
| Receptors, Somatostatin | 1 | 1998 | 138 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 1748 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2018 | 114 | 0.040 |
Why?
|
| Homozygote | 3 | 2008 | 1774 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2015 | 54812 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 1998 | 6493 | 0.030 |
Why?
|
| Wounds, Penetrating | 1 | 1999 | 316 | 0.030 |
Why?
|
| Patients | 1 | 2004 | 908 | 0.030 |
Why?
|
| Binding Sites | 2 | 2003 | 6001 | 0.030 |
Why?
|
| Brain Chemistry | 2 | 1998 | 951 | 0.030 |
Why?
|
| Photomicrography | 1 | 1996 | 71 | 0.030 |
Why?
|
| Genome-Wide Association Study | 3 | 2012 | 12803 | 0.030 |
Why?
|
| Linoleic Acids | 1 | 2016 | 39 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2004 | 834 | 0.030 |
Why?
|
| Middle Aged | 16 | 2021 | 223083 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2018 | 651 | 0.030 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4627 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1105 | 0.030 |
Why?
|
| Immune Sera | 1 | 1997 | 601 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5695 | 0.030 |
Why?
|
| Rib Fractures | 1 | 1978 | 124 | 0.030 |
Why?
|
| Adipocytes, Brown | 1 | 2017 | 160 | 0.030 |
Why?
|
| Nitriles | 1 | 2002 | 981 | 0.030 |
Why?
|
| Nitrogenous Group Transferases | 1 | 2016 | 3 | 0.030 |
Why?
|
| Maze Learning | 1 | 2018 | 482 | 0.030 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2016 | 11 | 0.030 |
Why?
|
| Fetus | 1 | 2004 | 1878 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1980 | 467 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 4423 | 0.030 |
Why?
|
| Perfusion | 1 | 2001 | 1408 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 1527 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1976 | 59 | 0.030 |
Why?
|
| Ganglia, Sensory | 1 | 1995 | 19 | 0.030 |
Why?
|
| Cerebellar Diseases | 1 | 2018 | 227 | 0.030 |
Why?
|
| Kinetics | 2 | 2021 | 6273 | 0.030 |
Why?
|
| Immediate-Early Proteins | 1 | 1998 | 444 | 0.030 |
Why?
|
| Viral Proteins | 2 | 2003 | 1801 | 0.030 |
Why?
|
| Aged | 10 | 2021 | 171219 | 0.030 |
Why?
|
| Drug Resistance | 2 | 1998 | 1592 | 0.030 |
Why?
|
| Pattern Recognition, Automated | 1 | 2021 | 979 | 0.030 |
Why?
|
| Tachykinins | 1 | 1995 | 78 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2016 | 187 | 0.030 |
Why?
|
| Fluorescent Dyes | 3 | 1999 | 1928 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2001 | 1322 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 13085 | 0.030 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 8724 | 0.030 |
Why?
|
| Depression | 1 | 2015 | 8230 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 322 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 16040 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2016 | 303 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 934 | 0.030 |
Why?
|
| Synovitis | 1 | 2016 | 209 | 0.030 |
Why?
|
| Administration, Topical | 1 | 1996 | 702 | 0.030 |
Why?
|
| Genome | 1 | 2002 | 1753 | 0.030 |
Why?
|
| Sialoglycoproteins | 1 | 1995 | 313 | 0.030 |
Why?
|
| Stem Cells | 1 | 2007 | 3537 | 0.030 |
Why?
|
| Genes, fos | 1 | 1994 | 176 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2013 | 41684 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1998 | 1227 | 0.030 |
Why?
|
| Walking | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Silver Staining | 1 | 1993 | 62 | 0.030 |
Why?
|
| Burns | 1 | 1985 | 1904 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 1995 | 299 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 428 | 0.030 |
Why?
|
| Cell Membrane | 3 | 2007 | 3635 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 12976 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1996 | 534 | 0.030 |
Why?
|
| Cholestenones | 1 | 2013 | 6 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 1993 | 151 | 0.030 |
Why?
|
| RNA | 3 | 2001 | 2716 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2012 | 1769 | 0.030 |
Why?
|
| Cross-Over Studies | 3 | 2005 | 2108 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2001 | 2762 | 0.030 |
Why?
|
| Estrogens | 1 | 2020 | 1528 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 1206 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2013 | 55 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 856 | 0.030 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1992 | 55 | 0.030 |
Why?
|
| Glycogen | 1 | 1993 | 252 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 4565 | 0.030 |
Why?
|
| Thiolester Hydrolases | 1 | 1993 | 91 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 1363 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 2005 | 4853 | 0.030 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 17071 | 0.030 |
Why?
|
| Diazepam | 1 | 1993 | 215 | 0.030 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1993 | 171 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 1132 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 563 | 0.030 |
Why?
|
| Lectins | 2 | 2006 | 487 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 615 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2012 | 8 | 0.030 |
Why?
|
| Class Ib Phosphatidylinositol 3-Kinase | 1 | 2012 | 42 | 0.030 |
Why?
|
| Quinolinium Compounds | 1 | 2012 | 10 | 0.030 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1992 | 47 | 0.020 |
Why?
|
| Intraocular Pressure | 1 | 2018 | 1304 | 0.020 |
Why?
|
| Atrophy | 1 | 1997 | 1629 | 0.020 |
Why?
|
| Electron Transport | 1 | 2013 | 211 | 0.020 |
Why?
|
| Second Messenger Systems | 1 | 1993 | 203 | 0.020 |
Why?
|
| Tail | 2 | 1984 | 91 | 0.020 |
Why?
|
| Streptozocin | 1 | 2012 | 189 | 0.020 |
Why?
|
| Research | 1 | 2000 | 1975 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 1980 | 1832 | 0.020 |
Why?
|
| Arthropod Antennae | 1 | 2011 | 17 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2002 | 5126 | 0.020 |
Why?
|
| Optic Nerve | 1 | 2015 | 568 | 0.020 |
Why?
|
| Piperazines | 2 | 2013 | 2547 | 0.020 |
Why?
|
| Histidine | 1 | 2012 | 301 | 0.020 |
Why?
|
| Swine | 1 | 2021 | 5986 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 2627 | 0.020 |
Why?
|
| Diaphragm | 1 | 2013 | 357 | 0.020 |
Why?
|
| Australia | 1 | 2015 | 1260 | 0.020 |
Why?
|
| Benzoxazoles | 1 | 2012 | 93 | 0.020 |
Why?
|
| Benzazepines | 1 | 2013 | 308 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1920 | 0.020 |
Why?
|
| Sirolimus | 1 | 2018 | 1541 | 0.020 |
Why?
|
| Biopsy | 1 | 2022 | 6768 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 1130 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4016 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2014 | 665 | 0.020 |
Why?
|
| Injections, Intraventricular | 2 | 1981 | 227 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 392 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 186 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2019 | 5382 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2012 | 433 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1994 | 2469 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 1993 | 455 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2010 | 107 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 260 | 0.020 |
Why?
|
| Electrodes | 1 | 1992 | 610 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2015 | 811 | 0.020 |
Why?
|
| Imidazoles | 2 | 2008 | 1169 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 262 | 0.020 |
Why?
|
| Fentanyl | 1 | 1993 | 451 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 1117 | 0.020 |
Why?
|
| Anesthesia, Conduction | 1 | 1993 | 264 | 0.020 |
Why?
|
| Iron | 1 | 2018 | 1811 | 0.020 |
Why?
|
| Thorax | 1 | 1993 | 554 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2015 | 772 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2016 | 864 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2011 | 248 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 2476 | 0.020 |
Why?
|
| Reflex, Monosynaptic | 2 | 1986 | 5 | 0.020 |
Why?
|
| Body Temperature | 3 | 1980 | 781 | 0.020 |
Why?
|
| Larva | 1 | 2011 | 511 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2016 | 1610 | 0.020 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2013 | 260 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2039 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22344 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 964 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2018 | 2590 | 0.020 |
Why?
|
| Hippocampus | 2 | 2015 | 3773 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2014 | 1099 | 0.020 |
Why?
|
| Respiration | 2 | 2013 | 1653 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 661 | 0.020 |
Why?
|
| Quisqualic Acid | 1 | 1988 | 35 | 0.020 |
Why?
|
| Lasers | 1 | 2013 | 951 | 0.020 |
Why?
|
| Tyrosine | 1 | 2013 | 1427 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 419 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 6544 | 0.020 |
Why?
|
| Survival Rate | 1 | 2022 | 12827 | 0.020 |
Why?
|
| Cell Division | 1 | 1995 | 4466 | 0.020 |
Why?
|
| Sleep | 1 | 2024 | 4816 | 0.020 |
Why?
|
| Cysteine | 1 | 2013 | 898 | 0.020 |
Why?
|
| Guanethidine | 1 | 2007 | 14 | 0.020 |
Why?
|
| Mammary Arteries | 1 | 2008 | 81 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 1996 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2015 | 14747 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1995 | 1962 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2795 | 0.020 |
Why?
|
| Models, Animal | 1 | 2014 | 2120 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 992 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2015 | 1021 | 0.020 |
Why?
|
| Hand | 2 | 2006 | 909 | 0.020 |
Why?
|
| Young Adult | 2 | 2017 | 59868 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1992 | 1616 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1988 | 386 | 0.020 |
Why?
|
| Sympathectomy | 1 | 2007 | 72 | 0.020 |
Why?
|
| Superoxides | 1 | 2008 | 382 | 0.020 |
Why?
|
| Hydroxydopamines | 3 | 1975 | 59 | 0.020 |
Why?
|
| Pressure | 2 | 1986 | 1171 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2221 | 0.020 |
Why?
|
| Back Pain | 1 | 2010 | 546 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2012 | 2342 | 0.020 |
Why?
|
| Fenclonine | 2 | 1977 | 16 | 0.020 |
Why?
|
| Genome, Human | 1 | 2019 | 4443 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2021 | 65219 | 0.020 |
Why?
|
| Antibodies | 1 | 1994 | 2415 | 0.020 |
Why?
|
| Tocainide | 1 | 1985 | 5 | 0.020 |
Why?
|
| Perceptual Distortion | 1 | 2006 | 36 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2007 | 367 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1992 | 1155 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 1985 | 186 | 0.020 |
Why?
|
| Neuritis | 1 | 2005 | 35 | 0.020 |
Why?
|
| Genes, gag | 1 | 2005 | 59 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6545 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2006 | 120 | 0.020 |
Why?
|
| Smad8 Protein | 1 | 2005 | 17 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1727 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 938 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 2003 | 0.020 |
Why?
|
| Smad5 Protein | 1 | 2005 | 26 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2005 | 48 | 0.020 |
Why?
|
| Genetic Variation | 2 | 2013 | 6612 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2001 | 2271 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2005 | 40 | 0.020 |
Why?
|
| Disease Progression | 1 | 2002 | 13616 | 0.020 |
Why?
|
| Saphenous Vein | 1 | 2008 | 519 | 0.020 |
Why?
|
| Mitochondria | 1 | 2018 | 3672 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 1194 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2824 | 0.020 |
Why?
|
| Gene Deletion | 2 | 2005 | 2667 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1986 | 551 | 0.010 |
Why?
|
| Burns, Chemical | 1 | 1985 | 123 | 0.010 |
Why?
|
| Kidney | 1 | 2000 | 7072 | 0.010 |
Why?
|
| Rats, Inbred F344 | 2 | 1996 | 820 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1993 | 2249 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2006 | 343 | 0.010 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2003 | 15 | 0.010 |
Why?
|
| Receptors, Purinergic P2X3 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2012 | 1051 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 203 | 0.010 |
Why?
|
| tau Proteins | 1 | 2014 | 2110 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 18076 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 59515 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 4521 | 0.010 |
Why?
|
| Mastectomy | 1 | 2012 | 1848 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2018 | 42511 | 0.010 |
Why?
|
| Receptors, Prostaglandin E, EP1 Subtype | 1 | 2003 | 9 | 0.010 |
Why?
|
| Epididymis | 1 | 2005 | 227 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2003 | 310 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3610 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 4780 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1600 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10433 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1984 | 232 | 0.010 |
Why?
|
| Neuregulin-1 | 1 | 2003 | 140 | 0.010 |
Why?
|
| Lentivirus | 1 | 2005 | 518 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2005 | 561 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 610 | 0.010 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 1984 | 240 | 0.010 |
Why?
|
| Vinblastine | 1 | 1984 | 483 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 2946 | 0.010 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2003 | 151 | 0.010 |
Why?
|
| Differential Threshold | 1 | 1982 | 80 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 788 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 24276 | 0.010 |
Why?
|
| Dyspnea | 1 | 1970 | 1351 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 614 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 501 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13468 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 29912 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3140 | 0.010 |
Why?
|
| Radiation Hybrid Mapping | 1 | 2001 | 16 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1981 | 82 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2017 | 3787 | 0.010 |
Why?
|
| Auditory Perception | 1 | 2006 | 586 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1984 | 770 | 0.010 |
Why?
|
| Uterus | 1 | 2005 | 660 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3892 | 0.010 |
Why?
|
| Diuresis | 1 | 1981 | 107 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2001 | 183 | 0.010 |
Why?
|
| Ovary | 1 | 2005 | 961 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 965 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 541 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 898 | 0.010 |
Why?
|
| Biological Transport | 2 | 1996 | 2080 | 0.010 |
Why?
|
| Bacillus thuringiensis | 2 | 1976 | 12 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1980 | 612 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2004 | 1638 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1970 | 1941 | 0.010 |
Why?
|
| Cats | 1 | 1981 | 972 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 1981 | 616 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 4112 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2001 | 578 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2001 | 432 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2142 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20700 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2007 | 1263 | 0.010 |
Why?
|
| Medulla Oblongata | 1 | 1980 | 247 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1980 | 367 | 0.010 |
Why?
|
| Callithrix | 1 | 1998 | 95 | 0.010 |
Why?
|
| Child | 2 | 2018 | 80573 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2001 | 1677 | 0.010 |
Why?
|
| Ketamine | 1 | 2004 | 527 | 0.010 |
Why?
|
| Periaqueductal Gray | 1 | 1998 | 111 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15827 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2012 | 6421 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2001 | 1984 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 573 | 0.010 |
Why?
|
| Forearm | 1 | 1979 | 426 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2008 | 2078 | 0.010 |
Why?
|
| Skin Temperature | 1 | 1977 | 96 | 0.010 |
Why?
|
| Electricity | 1 | 1977 | 173 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 2174 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1998 | 1167 | 0.010 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 1996 | 7 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1996 | 113 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1897 | 0.010 |
Why?
|
| Alleles | 1 | 2007 | 6892 | 0.010 |
Why?
|
| Ribs | 1 | 1977 | 256 | 0.010 |
Why?
|
| Nicotinic Acids | 1 | 1975 | 33 | 0.010 |
Why?
|
| Reserpine | 1 | 1975 | 63 | 0.010 |
Why?
|
| Protein Transport | 1 | 2001 | 1939 | 0.010 |
Why?
|
| Theophylline | 1 | 1975 | 132 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1975 | 171 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 4213 | 0.010 |
Why?
|
| Face | 1 | 1981 | 1029 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12061 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2008 | 3594 | 0.010 |
Why?
|
| Cyprinidae | 1 | 1974 | 35 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1994 | 97 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 2510 | 0.010 |
Why?
|
| Fura-2 | 1 | 1994 | 107 | 0.010 |
Why?
|
| Cytidine | 1 | 1974 | 59 | 0.010 |
Why?
|
| Salmonella typhi | 1 | 1976 | 201 | 0.010 |
Why?
|
| Receptors, Kainic Acid | 1 | 1994 | 91 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 1886 | 0.010 |
Why?
|
| Uridine | 1 | 1974 | 135 | 0.010 |
Why?
|
| Heart Rate | 1 | 1985 | 4204 | 0.010 |
Why?
|
| Kynurenic Acid | 1 | 1993 | 44 | 0.010 |
Why?
|
| Thoracic Surgery | 1 | 1980 | 727 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 26290 | 0.010 |
Why?
|
| Attention | 1 | 2004 | 2415 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1993 | 227 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1996 | 1695 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 2898 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1998 | 933 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4617 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 1977 | 635 | 0.010 |
Why?
|
| Ischemia | 1 | 1979 | 1904 | 0.010 |
Why?
|
| Virus Replication | 1 | 1998 | 2458 | 0.010 |
Why?
|
| Liver | 1 | 2006 | 7559 | 0.010 |
Why?
|
| Lung Compliance | 1 | 1970 | 207 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1975 | 1239 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 88819 | 0.000 |
Why?
|
| Elasticity | 1 | 1970 | 652 | 0.000 |
Why?
|
| Physical Exertion | 1 | 1970 | 666 | 0.000 |
Why?
|
| Spirometry | 1 | 1970 | 929 | 0.000 |
Why?
|
| Fractures, Bone | 1 | 1977 | 2041 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2012 | 81565 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1996 | 9237 | 0.000 |
Why?
|
| Oxygen | 1 | 1970 | 4247 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1978 | 323 | 0.000 |
Why?
|
| Hypothalamus, Anterior | 1 | 1976 | 12 | 0.000 |
Why?
|
| Adenine Nucleotides | 1 | 1976 | 111 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1978 | 839 | 0.000 |
Why?
|
| Potassium | 1 | 1978 | 1312 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1978 | 3946 | 0.000 |
Why?
|
| Energy Metabolism | 1 | 1978 | 2894 | 0.000 |
Why?
|